Effect of valsartan on level of C-reactive protein in acute coronary syndrome patients after PCI

Chen Hui,Yan Youliang,Liu Liyun
DOI: https://doi.org/10.3969/j.issn.1006-2238.2008.09.004
2008-01-01
Abstract:Objective To investigate the effect of valsartan on the levels of C-reactive protein(CRP) in acute coronary syndrome patients after percutaneous coronary intervention(PCI).Methods 78 acute coronary syndrome patients received sucessful PCI were randomly divided into conventional therapy group (40) and vasarltan group (38).Venous blood samples were taken before,at 24 hours,1 month,3 months and 6 months after PCI in both groups, and serum samples were analyzed for CRP.Results At 6 months after PCI,the levels of CRP had statistical significant difference between the two groups (P<0.05).Conclusion Vasarltan can decrease the levels of CRP and suppress inflammatory reaction to prevent restenosis in stents in acute coronary syndrome patients after PCI.
What problem does this paper attempt to address?